BE study design issue [Design Issues]

posted by Dr_Dan  – 2019-12-18 15:04 (643 d 21:51 ago) – Posting: # 20992
Views: 2,401

Hi John
if the recommended dosage regimen of the IR as per product monograph IR is to be given every 4 hrs then this means that higher doses have either a safety issue or the dose/effect relationship is in disfavor of higher doses. In this case AUC alone does not matter. Consequently, a regulatory body will reject the study
Hope this helps

Kind regards and have a nice day

Complete thread:

 Admin contact
21,691 posts in 4,534 threads, 1,541 registered users;
online 7 (0 registered, 7 guests [including 4 identified bots]).
Forum time: Wednesday 13:56 CEST (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz